Kisqali on Humana Basic Rx Plan (S5884-139)
ribociclib
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 21 per 28 days.
$1,914.47
Patient pays / month, after deductible
$2,375.72
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
KISQALI 200 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $7,657.89 for a month. Other covered strengths are listed below.
Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| KISQALI 200 mg Tablet, Film Coated | 5 | $1,914.47 | PA · 21 per 28 days |
| KISQALI 200 mg Tablet, Film Coated | 5 | $3,896.82 | PA · 42 per 28 days |
| KISQALI 200 mg Tablet, Film Coated | 5 | $4,883.79 | PA · 63 per 28 days |
Other CDK4/6 inhibitors on this plan
Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5884-139